Mirae Asset Global Investments Cuts Holdings in Seelos Therapeutics Amid Shifting Investment Trends in Biotech Start-Ups
As of May 31, 2023, the investment firm Mirae Asset Global Investments Co. Ltd. has reportedly reduced its holdings of ...
Tag: SEEL
Seelos Therapeutics Reports Q1 2023 Financial Results and Clinical Updates
On May 16, 2023, Seelos Therapeutics, a clinical-stage biopharmaceutical company, released its financial results and clinical updates for the first ...
Seelos Therapeutics Receives Overweight Rating from Cantor Fitzgerald Analyst with Lowered Price Target
As of May 16, 2023, Seelos Therapeutics (NASDAQ:SEEL) is receiving an Overweight rating from Cantor Fitzgerald analyst Charles Duncan, who ...